Wednesday, 23 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14475
Articles
Company
Deals
Dartsbio Licenses Potential First-in-Class BsAb DS005 to Duality Biologics
March 3, 2025
Company
Deals
Fosun Pharma Terminates Equity Transfer Deal with OncoCare Medical
February 1, 2025
Company
Drug
Antengene’s CD73 Inhibitor ATG-037 Greenlit for Phase I Study by NMPA
February 1, 2025
Company
Medical Device
Sino Medical Sciences’ Non-Compliant Balloon Catheter Approved by NMPA
February 1, 2025
Company
Drug
Hengrui’s Pyrotinib Granted Breakthrough Therapy Designation by CDE
February 1, 2025
Company
Drug
NMPA Approves Humanwell’s Generic Clobazam for Lennox-Gastaut Syndrome
August 26, 2025
Company
Drug
NMPA Approves Luye Pharma’s LY03005 for Depression Treatment
February 1, 2025
Company
Drug
Shanghai SMPA Suspends HEC’s Linagliptin Procurement Over Patent Infringement
February 1, 2025
Company
Drug
Shanghai Pharmaceuticals Gets NMPA Clearance for Sublingual Rasagiline
February 1, 2025
Company
Deals
Baidu Health Partners with Shanghai Epiprobe for Cancer Early Screening
February 1, 2025
Company
Deals
Pharmaniaga Partners with JD.com to Enter China Market
February 1, 2025
Company
Drug
Eli Lilly’s Peresolimab and LOXO-783 Gain Tacit Clinical Trial Approvals in China
February 1, 2025
1
2
…
1,108
1,109
1,110
1,111
1,112
…
1,206
1,207
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?